WEREWOLF THERAPEUTICS, INC. Increase (Decrease) in Other Operating Liabilities
WEREWOLF THERAPEUTICS, INC. (HOWL) reported Increase (Decrease) in Other Operating Liabilities of -$191.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2023-11-14
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in other operating liabilities for the quarter ending 2023-09-30 was $0.00.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in other operating liabilities for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in other operating liabilities for the quarter ending 2023-03-31 was -$191.00K.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in other operating liabilities for the quarter ending 2022-12-31 was $0.00.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in other operating liabilities for fiscal 2022 was $191.00K.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in other operating liabilities for fiscal 2021 was -$31.00K, a 487.50% decline from fiscal 2020.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in other operating liabilities for fiscal 2020 was $8.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | -$191.00K 10-Q · filed 2023-11-14 | -$191.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$191.00K 10-Q · filed 2023-08-10 | -$191.00K derived: sum of 3 quarters · filed 2023-08-10 | -$191.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-03-31 | -$191.00K 10-Q · filed 2023-05-11 | -$191.00K derived: sum of 2 quarters · filed 2023-05-11 | -$191.00K derived: sum of 3 quarters · filed 2023-11-14 | $0.00 derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $191.00K derived: sum of 3 quarters · filed 2023-11-14 | $191.00K 10-K · filed 2023-03-23 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $191.00K derived: sum of 2 quarters · filed 2023-11-14 | $191.00K 10-Q · filed 2023-11-14 | $191.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $191.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $191.00K 10-Q · filed 2023-08-10 | $191.00K derived: sum of 3 quarters · filed 2023-08-10 | $191.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-05-11 | $0.00 derived: sum of 3 quarters · filed 2023-05-11 | -$81.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $0.00 derived: sum of 2 quarters · filed 2023-03-23 | -$81.00K derived: sum of 3 quarters · filed 2023-03-23 | -$31.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$81.00K derived: sum of 2 quarters · filed 2022-11-10 | -$31.00K 10-Q · filed 2022-11-10 | $0.00 derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$31.00K 10-Q · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2022-08-11 | -$9.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $50.00K 10-Q · filed 2022-05-10 | $81.00K derived: sum of 2 quarters · filed 2022-05-10 | $72.00K derived: sum of 3 quarters · filed 2022-05-10 | $69.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $22.00K derived: sum of 2 quarters · filed 2022-03-24 | $19.00K derived: sum of 3 quarters · filed 2022-03-24 | $8.00K 10-K · filed 2022-03-24 |
| 2020-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$12.00K derived: sum of 2 quarters · filed 2021-11-10 | -$23.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$14.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$11.00K 10-Q · filed 2021-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |